Myeloid Dendritic Cells from Human Cutaneous Squamous Cell Carcinoma Are Poor Stimulators of T-Cell Proliferation
- 1 October 2009
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 129 (10), 2451-2462
- https://doi.org/10.1038/jid.2009.96
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Resident and “Inflammatory” Dendritic Cells in Human SkinJournal of Investigative Dermatology, 2009
- Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic CellsJournal of Investigative Dermatology, 2009
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activityBlood, 2008
- IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammationJCI Insight, 2008
- Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responsesThe Journal of Experimental Medicine, 2007
- Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophagesJCI Insight, 2007
- Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional responseCancer Letters, 2007
- Tumoricidal activity of TLR7/8-activated inflammatory dendritic cellsThe Journal of Experimental Medicine, 2007
- Oral immune tolerance mediated by suppressor T cells may be responsible for the poorer prognosis of foregut cancersMedical Hypotheses, 2006
- IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesisThe Journal of Experimental Medicine, 2006